pageInfo({
    time : "1261111420094"
  
	    , page : null
	  
	    , url : null
	  
	    , instrument : null
	  
	    , article : {
	        storyId : "UKN0838429720090708"
	        , headline : "Investors warm to Amgen following bone drug data"
	        , keywords : "[Pharmaceuticals (sub-industry), Health and medicine, United States of America, Europe, Switzerland, Western Europe, Biotechnology, Chemicals, Pharmaceuticals - diversified, Pharmaceuticals - generic and speciality, United Kingdom, France, Household products, Food products, Economic news, EC, business/financial pages]"
	        , tickers : "[xt;RO, mx;PG, NOVN.VX, pe;MRK, pe;PG, PG.N, ROG.VX, SASY.PA, us;AMGN, us;GLAX, us;GSK, us;MRK, us;PG, us;RHHQ, us;RHHV, us;SNY, us;SNYN, mx;MRK, mx;GSKN, mx;AMGN, ch;AMGN, ch;MRK, ch;NOV, ch;RO, de;GS7, de;RHO, de;RHOF, fr;MRK, fr;PG, fr;SAN, gb;AP47, gb;GSK, gb;PGM, gb;SNF, GSK.L, it;SANF, AMGN.O]"
	    }
	    , channel : {
	        id : "54"
	        , name : "companyNews"
	        , title : "Company News"
	    }})